These findings suggest that CA suppresses leptin-induced MMP-1 expression by modulating specific signaling pathways, highlighting its potential as a therapeutic agent for IVD degeneration associated with obesity. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.